Imagen de Portada

Spindle-cell carcinoma of the prostate

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	Carlos Hirokatsu Watanabe Silva
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Hospital Universitário da Universidade de São Paulo 2012
Materias:	Medicina Sarcoma Prostate Carcinoma
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clear cell variant of oral squamous cell carcinoma: case report and review
por: Rutuja Narsing Mukkanwar
Publicado: (2022)

Sarcoma de Ewing extraóseo del quinto ortejo del pie izquierdo: reporte de caso
por: Juan Carlos Daniel-Fuster
Publicado: (2017)

Spindle cell carcinoma of the maxillary sinus with extension to the oral cavity
por: Alejandro Donohue-Cornejo
Publicado: (2020)

Experiencia en el tratamiento de los sarcomas de novo: en la glándula mamaria
por: Felipe Saldivia
Publicado: (2005)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
por: Shingo Ashida, et al.
Publicado: (2024)

Three‐dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice
por: Kei‐Ichiro Uemura, et al.
Publicado: (2024)

Sarcoma de Ewing extraesquelético: relato de um caso raro e exuberante simulando lipoma
por: Melissa de Almeida Corrêa Alfredo
Publicado: (2023)

Targeting proliferating cell nuclear antigen enhances ionizing radiation‐induced cytotoxicity in prostate cancer cells
por: Shan Lu, et al.
Publicado: (2024)

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells
por: Chia‐Ling Hsieh, et al.
Publicado: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
por: Eric V. Li, et al.
Publicado: (2024)

Sarcoma sinovial intraoral primario monofásico
por: PATRICIO GAC E.
Publicado: (2008)

Comparative antiproliferation of human prostate cancer cells by ethanolic extracts of two groups of Brazilian propolis
por: Cleber Silveira MORAES
Publicado: (2010)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
por: Zain Abedali, et al.
Publicado: (2024)

Diagnosis and management of neuroendocrine prostate cancer
por: Ivan de Kouchkovsky, et al.
Publicado: (2024)

Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy
por: Fabio Matrone, et al.
Publicado: (2024)

Other‐cause mortality in incidental prostate cancer
por: Francesco Di Bello, et al.
Publicado: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
por: Pranav Prakash, et al.
Publicado: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
por: Kamil Malshy, et al.
Publicado: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
por: Yirui Wei, et al.
Publicado: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
por: Tianwei Jia, et al.
Publicado: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
por: Reyhane Karegar‐Niavol, et al.
Publicado: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
por: Thomas Büttner, et al.
Publicado: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
por: Xiangbin Kong, et al.
Publicado: (2024)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
por: Hongbo Chai, et al.
Publicado: (2024)

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate
por: Chinade Roper, et al.
Publicado: (2024)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
por: Ruth Himmelsbach, et al.
Publicado: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
por: Matteo Massanova, et al.
Publicado: (2024)

Sarcoma pleomórfico primário do pulmão - 11 anos de sobrevivência
por: M.J. Gonçalves
Publicado: (2011)

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
por: Fabian Falkenbach, et al.
Publicado: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
por: Sean A. Fletcher, et al.
Publicado: (2024)

Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing
por: Stephen Schmit, et al.
Publicado: (2024)

Performance of large language models on benign prostatic hyperplasia frequently asked questions
por: YuNing Zhang, et al.
Publicado: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
por: Shuhei Kamada, et al.
Publicado: (2024)

Development and validation of an imageless machine‐learning algorithm for the initial screening of prostate cancer
por: Nicolas Martelin, et al.
Publicado: (2024)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
por: Ghazi Alanazi, et al.
Publicado: (2024)

Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome
por: Eli Marie Grindedal, et al.
Publicado: (2024)

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis
por: Pengfei Zhang, et al.
Publicado: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
por: Michal Jirásko, et al.
Publicado: (2024)

Real‐world study: Impact of multidisciplinary management of apalutamide‐associated adverse events in prostate cancer
por: Julián Córdoba Sánchez, et al.
Publicado: (2024)

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
por: Takafumi Yanagisawa, et al.
Publicado: (2024)